Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Empagliflozin 25 mg film-coated tablets vs JARDIANCE 25 mg in healthy Thai adults under fasting conditions
TCTR20251104005Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of empagliflozin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Bio-innova. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
empagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20251104005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251104005.